Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
about
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus PanelTransperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.Trends in prostate cancer incidence and mortality in Croatia, 1988-2008Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients.Hematoma in Retzius' space following US-guided prostate biopsy: evidence of the diagnostic accuracy using transrectal end-fire probe in the anterior prostate gland.Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer.Recent advances in magnetic resonance imaging of prostate cancer.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.A biomedical engineering approach to mitigate the errors of prostate biopsy.Prostate saturation biopsy following a first negative biopsy: state of the art.Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy.Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy.Optimization of prostate biopsy: review of technique and complications.Random biopsy: when, how many and where to take the cores?Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy.Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method.How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three-dimensional analysis.Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue.Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.MR imaging-guided prostate biopsy: technical features and preliminary results.Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms
P2860
Q26822832-027FB1DC-ACF2-434D-A672-D2DC0D2AABD0Q35106786-48FC1461-65E8-4BB3-884D-CC59ABFD3EC7Q35929312-4D7495ED-718F-4B2D-BA74-8FB244EFD1E3Q37009160-CE513618-B211-4E9B-8B1E-23A72BD6E617Q37622343-AA3A4552-CC22-4AB1-B066-46FDC3A4611FQ37768170-B0D51DA0-A907-459D-BA55-8575A5D8A1D9Q37833928-C0CA15C9-2DB5-4549-BE32-9399ADB945E8Q37892629-0D75CBE3-E554-499C-955E-19B4665C5E2CQ37981828-18CF357E-F9B0-4DDD-A385-A3230BBC4A83Q38027698-3CBD27EB-A03D-40AA-9C23-03B960868464Q38121878-629987EB-2113-4618-BBFC-B9DE661FD41EQ38160496-FF6F3CEC-58F7-4F8E-BEBB-8FBA77F2D30EQ38203986-6B033AC7-2AD8-4E2E-898E-4F26CC14D9BDQ38218443-8F2DC67E-1441-4664-AB8F-D23A92D42CD5Q38222963-5259AC47-D405-42BF-B8C7-8EFF44922BBFQ38808009-8106BF31-7764-4516-9616-0D196ECBDBACQ39405854-4508A586-8263-443C-AFD4-C94E0E38FBD0Q40010533-86070AEC-07D1-4189-A271-2A5E633EE7B8Q40184478-F3AD7A23-4E55-49EE-9A01-E972EC82823BQ41255229-244FADCA-285C-417A-B3DC-FA84AB08AC24Q41901097-18DADD95-12DA-4F9F-BE58-A2ADD0662E43Q42676794-1E1FD46C-7363-4828-AD87-FE8118FE4168Q46922611-5D05FA8D-7AAF-4F6A-80F5-22BBA7EB37F5Q47734142-974FE958-CEC1-454A-BD2A-BFBBF8E49EE0Q48145024-7B6DF43E-997D-497A-8466-13F6A8B286CBQ48280936-B56831C3-4AF3-47BB-BF1E-41F98A4F5A04Q51731326-97F98A79-279E-462A-80BF-FFE6522936D0Q53091492-FCF15B70-E689-49DB-89EB-888E6D35AFC6Q53341367-576A10A2-76A5-4524-8CF6-B5305B1B7261Q57238737-45307666-9D69-480C-AE45-F097988A778D
P2860
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@en
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@nl
type
label
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@en
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@nl
prefLabel
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@en
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@nl
P2093
P50
P1433
P1476
Biopsy schemes with the fewest ...... detected by a 24-core biopsy.
@en
P2093
Carmen Maccagnano
Diego Angiolilli
Federico Dehò
Marco Raber
Massimo Freschi
Patrizio Rigatti
Vincenzo Scattoni
P356
10.1016/J.EURURO.2009.08.011
P407
P577
2009-08-19T00:00:00Z